BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17447845)

  • 1. Population stratification of a common APOBEC gene deletion polymorphism.
    Kidd JM; Newman TL; Tuzun E; Kaul R; Eichler EE
    PLoS Genet; 2007 Apr; 3(4):e63. PubMed ID: 17447845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
    Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
    J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals.
    Prasetyo AA; Sariyatun R; Reviono ; Sari Y; Hudiyono ; Haryati S; Adnan ZA; Hartono ; Kageyama S
    J Clin Virol; 2015 Sep; 70():67-71. PubMed ID: 26305823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3B deletion and risk of HIV-1 acquisition.
    An P; Johnson R; Phair J; Kirk GD; Yu XF; Donfield S; Buchbinder S; Goedert JJ; Winkler CA
    J Infect Dis; 2009 Oct; 200(7):1054-8. PubMed ID: 19698078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide population distribution of the common LCE3C-LCE3B deletion associated with psoriasis and other autoimmune disorders.
    Bassaganyas L; Riveira-Muñoz E; García-Aragonés M; González JR; Cáceres M; Armengol L; Estivill X
    BMC Genomics; 2013 Apr; 14():261. PubMed ID: 23594316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
    Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
    Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.
    Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):273-6. PubMed ID: 26320772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
    Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
    Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan.
    Chen CH; Wei KC; Liao WC; Lin YY; Chen HC; Feng LY; Liu CH; Huang CY; Chen KT; Wu CS; Chang YS; Yu JS; Chang IY
    J Neurosurg; 2023 May; 138(5):1325-1337. PubMed ID: 36152319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa.
    Matume ND; Tebit DM; Gray LR; Turner SD; Rekosh D; Bessong PO; Hammarskjöld ML
    BMC Med Genet; 2019 Jan; 20(1):21. PubMed ID: 30660178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
    Revathidevi S; Manikandan M; Rao AK; Vinothkumar V; Arunkumar G; Rajkumar KS; Ramani R; Rajaraman R; Ajay C; Munirajan AK
    Tumour Biol; 2016 Sep; 37(9):11983-11990. PubMed ID: 27155849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.
    Gansmo LB; Sofiyeva N; Bjørnslett M; Romundstad P; Hveem K; Vatten L; Dørum A; Lønning PE; Knappskog S
    Sci Rep; 2021 Dec; 11(1):23463. PubMed ID: 34873230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
    Liu J; Sieuwerts AM; Look MP; van der Vlugt-Daane M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
    PLoS One; 2016; 11(8):e0161731. PubMed ID: 27552096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3B deletion impacts on susceptibility to acquire HIV-1 and its advancement among individuals in western India.
    Singh H; Marathe SD; Nain S; Nema V; Ghate MV; Gangakhedkar RR
    APMIS; 2016 Oct; 124(10):881-7. PubMed ID: 27522954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of an association between the APOBEC3B deletion polymorphism and susceptibility to HIV infection and AIDS in Japanese and Indian populations.
    Itaya S; Nakajima T; Kaur G; Terunuma H; Ohtani H; Mehra N; Kimura A
    J Infect Dis; 2010 Sep; 202(5):815-6; author reply 816-7. PubMed ID: 20684727
    [No Abstract]   [Full Text] [Related]  

  • 17. APOBEC3A/B deletion polymorphism and endometrial cancer risk.
    Sofiyeva N; Krakstad C; Halle MK; O'Mara TA; Romundstad P; Hveem K; Vatten L; Lønning PE; Gansmo LB; Knappskog S
    Cancer Med; 2023 Mar; 12(6):6659-6667. PubMed ID: 36394079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk.
    Imahashi M; Izumi T; Watanabe D; Imamura J; Matsuoka K; Ode H; Masaoka T; Sato K; Kaneko N; Ichikawa S; Koyanagi Y; Takaori-Kondo A; Utsumi M; Yokomaku Y; Shirasaka T; Sugiura W; Iwatani Y; Naoe T
    PLoS One; 2014; 9(3):e92861. PubMed ID: 24667791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome.
    Conrad DF; Jakobsson M; Coop G; Wen X; Wall JD; Rosenberg NA; Pritchard JK
    Nat Genet; 2006 Nov; 38(11):1251-60. PubMed ID: 17057719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short tandem repeat polymorphism evolution in humans.
    Calafell F; Shuster A; Speed WC; Kidd JR; Kidd KK
    Eur J Hum Genet; 1998 Jan; 6(1):38-49. PubMed ID: 9781013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.